TTK Healthcare Limited (BOM:507747)
1,082.70
+34.15 (3.26%)
At close: Jul 27, 2026
TTK Healthcare Market Cap
TTK Healthcare has a market cap or net worth of 15.3 billion as of July 27, 2026. Its market cap has decreased by -16.46% in one year.
Market Cap
15.30B
Enterprise Value
6.18B
Revenue
8.57B
Ranking
n/a
PE Ratio
23.29
Stock Price
1,082.70
ChartMarket Cap Chart
Since May 28, 2001, TTK Healthcare's market cap has increased from 107.39M to 15.30B, an increase of 14,146.30%. That is a compound annual growth rate of 21.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 15.30B | 4.54% |
| Dec 31, 2025 | 14.63B | -26.89% |
| Dec 31, 2024 | 20.02B | 0.51% |
| Dec 29, 2023 | 19.92B | 40.43% |
| Dec 30, 2022 | 14.18B | 41.69% |
| Dec 31, 2021 | 10.01B | 18.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 22.06B |
| Fredun Pharmaceuticals | 14.80B |
| Amrutanjan Health Care | 14.76B |
| Shukra Pharmaceuticals | 13.94B |
| Fermenta Biotech | 12.40B |
| Syncom Formulations (India) | 12.31B |
| Lincoln Pharmaceuticals | 11.66B |
| Wanbury | 11.60B |